Arcellx
Adaptive Immune Cell Therapies
2
Funding Rounds
$200.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Arcellx has raised a total of $200m in funding over 2 rounds.
Key Insights:
- ArcellX Series C round, April 2021: $115m
- Arcellx Series B round, October 2019: $85m
ArcellX Series C round, April 2021
$115m
Arcellx Series B round, October 2019
$85m
Industries
Arcellx is active in the following industries:
- Engineering
- Biomedical engineering
- Biopharmaceutical
- Technology
- Biology
- Biotechnology
- Healthcare
- Regenerative medicine
- Cell therapy
- Tissue engineering
- Immunotherapy